A pilot study of high-adsorption hemofiltration in human septic shock

International Journal of Artificial Organs

Volumn 30, Issue 2, 2007, Pages 108-117

  Haase, M ^a   Silvester, W ^a   Uchino, S ^a   Goldsmith, D ^a   Davenport, P ^b   Tipping, P ^b   Boyce, N ^a   Bellomo, Rinaldo ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b MONASH MEDICAL CENTRE   (Australia)

Author keywords

Cytokines; Hemofiltration; Interleukin 10; Interleukin 6; Multiorgan failure; Septic shock

Indexed keywords

AMINES; BLOOD PRESSURE; DIALYSIS; INTENSIVE CARE UNITS; NEUROPHYSIOLOGY; NOREPINEPHRINE;

% REDUCTIONS; CYTOKINES; FILTER CHANGES; HAEMODYNAMICS; HEMOFILTRATION; INTERLEUKIN-10; INTERLEUKIN6 (IL6); MULTIORGAN FAILURE; PLASMA CONCENTRATION; SEPTIC SHOCKS;

ADSORPTION;

CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 18; INTERLEUKIN 6; INTERLEUKIN 8; NORADRENALIN;

ADULT; AGED; ARTERIAL PRESSURE; ARTICLE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL LABORATORY; CLINICAL TRIAL; CONTINUOUS HEMOFILTRATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; EX VIVO STUDY; FEMALE; HEMODYNAMICS; HUMAN; INTENSIVE CARE UNIT; MALE; MULTIPLE ORGAN FAILURE; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SEPTIC SHOCK; STATISTICAL SIGNIFICANCE;

EID: 34147152344     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139880703000205     Document Type: Article

References (20)

1. Tetta C, Mariano F, Ronco C, et al. Removal and generation of inflammatory mediators during continuous renal replacement therapies. Crit Care Nephrol 1998; 1239-48.
2. Manns M, Sigler MH, Teehan BP. Gontinuous renal replacement therapies: An update. Am J Kidney Dis 1998; 32: 185-207.
3. Schetz, M. Classical and alternative indications for CRRT. Kidney Int 1998; 53 (suppl 66): 129-32.
4. Rogiers P, Zhang H, Pauwels D, et al. Comparison of polyacrylonitrile (AN69) and polysulphone membrane during hemofiltration in canine endotoxic shock. Crit Gare Med 2003; 31: 1219-25.
5. Kellum JA, Dishart MK. Effect of hemofiltration filter adsorption on circulating IL-6 levels in septic rats. Crit Care 2002; 6: 429-33.
6. De Vriese AS, Colardyn FA, Philippe JJ, et al. Cytokine removal during continuous hemofiltration in septic patients. J Am Soc Nephrol 1999; 10: 846-53.
7. Bone RC, Balk RA, Gerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992; 101: 1644-55.
8. Cole L, Bellomo R, Journois D, et al. High-volume haemofiltration in human septic shock. Intensive Care Med 2001; 27: 978-86.
9. Heering P, Morgera S, Schmitz FJ, et al. Cytokine removal and cardiovascular hemodynamics in septic patients with continuous venovenous hemofiltration. Intensive Care Med 1997; 23: 288-96.
10. Sanchez-Izquierdo JA, Perez Vela JL, Lozano Quintana MJ, et al. Cytokines clearance during veno-venous hemofiltration in the trauma patient. Am J Kidney Dis 1997; 30: 483-8.
11. Grootendorst AF, van Bommel EF. The role of hemofiltration in the critically-ill intensive care unit patient: Present and future. Blood Purif 1993; 11: 209-23.
12. Gasche Y, Pascual M, Suter PM, et al. Complement depletion during haemofiltration with polyacrilonitrile membranes. Nephrol Dial Transplant 1996; 11: 117-9.
13. Cole L, Bellomo R, Hart G, et al. A phase II randomized, controlled trial of continuous hemofiltration in sepsis. Crit Care Med 2002; 30: 100-6.
14. Marie C, Losser MR, Fitting C, et al. Cytokines and soluble cytokine receptors in pleural effusions from septic and nonseptic patients. Am J Respir Crit Care Med 1997; 156: 1515-22.
15. Cavaillon JM, Munoz C, Fitting C, et al. Circulating cytokines: The tip of the iceberg? Circ Shock 1992; 38: 145-52.
16. Sieberth HG, Kierdorf HP. Is cytokine removal by continuous hemofiltration feasible? Kidney Int 1999; 72 (suppl): S79-83.
17. Webb LMC, Ehrengruber MU, Clark-Lewis I, et al. Binding to heparan sulfate or heparin enhances neutrophil responses to interleukin 8. Proc Natl Acad Sci 1993; 90: 7158-62.
18. Morgera S, Haase M, Kuss T, et al. Pilot study on the effects of high cutoff hemofiltration on the need for norepinephrine in septic patients with acute renal failure. Crit Care Med 2006; 34: 2099-104.
19. van Kuijk WH, Hillion D, Savoiu C, et al. Critical role of the extracorporeal blood temperature in the hemodynamic response during hemofiltration. J Am Soc Nephrol 1997; 8: 949-55.
20. Morgera S, Slowinski T, Melzer C, et al. Renal replacement therapy with high cut-off hemofilters: Impact of convection and diffusion on cytokine clearances and protein status. Am J Kidney Dis 2004; 43: 444-53.